{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:00:25Z","timestamp":1768878025710,"version":"3.49.0"},"reference-count":64,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomarkers Med."],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.2217\/bmm.11.53","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T19:57:02Z","timestamp":1314129422000},"page":"515-526","source":"Crossref","is-referenced-by-count":27,"title":["Prostate-Specific Antigen Testing Across the Spectrum of Prostate Cancer"],"prefix":"10.1080","volume":"5","author":[{"given":"Mark R","family":"Haythorn","sequence":"first","affiliation":[{"name":"The Robert Benjamin Ablin Foundation for Cancer Research, Tucson, AZ 85705, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"Ablin","sequence":"additional","affiliation":[{"name":"The Robert Benjamin Ablin Foundation for Cancer Research, Tucson, AZ 85705, USA."},{"name":"Department of Pathology University of Arizona College of Medicine, PO Box 245043, Tucson, AZ 85724, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,8,23]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031918"},{"key":"e_1_3_2_4_1","unstructured":"Ablin RJ WhyardTC. Immunobiological Implications of Select Bioactive Molecules in the Prostate with a Known and Unknown Target. In: The Prostate as an Endocrine Gland. Farnsworth WE Ablin RJ (Eds.). CRC Press Inc. Boca Raton 149 (1990)."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.04306.x"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0220573"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.104.6.1329"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197206)29:6<1570::AID-CNCR2820290621>3.0.CO;2-V"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.04366.x"},{"issue":"7","key":"e_1_3_2_10_1","first-page":"2428","article-title":"A prostate antigen in sera of prostatic cancer patients.","volume":"40","author":"Papsidero LD","year":"1980","unstructured":"Papsidero LD , WangMC, ValenzuelaLAet al. A prostate antigen in sera of prostatic cancer patients. Cancer Res. 40(7), 2428\u20132432 (1980).","journal-title":"Cancer Res."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327481101800103"},{"key":"e_1_3_2_12_1","volume-title":"WHO","author":"Wilson JMG","year":"1968","unstructured":"Wilson JMG , JungnerG. Principles and practice of screening for disease. Public Health Paper Number 34. Geneva, WHO (1968)."},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000474163"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.046086"},{"key":"e_1_3_2_15_1","first-page":"2234","article-title":"Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2,304 patients undergoing prostate cancer screening.","volume":"171","author":"Link RE","year":"2004","unstructured":"Link RE , ShariateSF, NguyenCVet al. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2,304 patients undergoing prostate cancer screening. Clin. Urol. 171(6, Part 1), 2234\u20132238 (2004).","journal-title":"Clin. Urol."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000083548"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.66"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.221"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603105"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0785-8"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810696"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810084"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.6373"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70146-7"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.016"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.607"},{"issue":"8","key":"e_1_3_2_27_1","first-page":"2576","article-title":"Quantifying the amount of variation in survival explained by prostate-specific antigen.","volume":"8","author":"Verbel DA","year":"2002","unstructured":"Verbel DA , HellerG, KellyWKet al. Quantifying the amount of variation in survival explained by prostate-specific antigen. Clin. Cancer Res. 8(8), 2576\u20132579 (2002).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10199"},{"issue":"1","key":"e_1_3_2_29_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0031-6997(24)01480-7","article-title":"The control of prostate-specific antigen expression and gene regulation by pharmacological agents","volume":"53","author":"Dixon SC","year":"2001","unstructured":"Dixon SC , KnopfKB, FiggWD. The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacol. Rev.53(1), 73\u201391 (2001).","journal-title":"Pharmacol. Rev."},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00182061"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040720"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.4769"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2009.11.012"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(00)00103-0"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050110"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66399-7"},{"issue":"18","key":"e_1_3_2_37_1","first-page":"6958","article-title":"A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer.","volume":"61","author":"Mikolajczyk SD","year":"2001","unstructured":"Mikolajczyk SD , MarkerKM, MillarLSet al. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. Cancer Res. 61(18), 6958\u20136963 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000095460.12999.43"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0007"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.01953.x"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwg041"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.08.009"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.14.1044"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001513"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09677"},{"key":"e_1_3_2_46_1","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Brussemakers MJ","year":"1999","unstructured":"Brussemakers MJ , van BokhovenA, VerhaeghGWet al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res.59, 5975\u20139 (1999).","journal-title":"Cancer Res."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605785"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.10.006"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4713"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp001"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540420048028"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji205"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp028"},{"issue":"7","key":"e_1_3_2_54_1","first-page":"742","article-title":"Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma.","volume":"9","author":"Allam CK","year":"1996","unstructured":"Allam CK , BostwickDG, HayesJAet al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod. Pathol. 9(7), 742\u2013751 (1996).","journal-title":"Mod. Pathol."},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00490-1"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08278-8"},{"key":"e_1_3_3_2_1","unstructured":"American Cancer Society. Prostate Cancer: Early Detection www.cancer.org\/Cancer\/ProstateCancer\/MoreInformation\/ProstateCancerEarlyDetection\/prostate-cancer-early-detection-toc"},{"key":"e_1_3_3_3_1","unstructured":"American Urological Association. Prostate-Specific Antigen Best Practice Statement: 2009 Update http:\/\/www.auanet.org\/content\/media\/psa09.pdf"},{"key":"e_1_3_3_4_1","unstructured":"National Comprehensive Cancer Network. Prostate Cancer Early Detection http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp)"},{"key":"e_1_3_3_5_1","unstructured":"United States Preventative Task Force. Screening for Prostate Cancer http:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/uspsprca.htm)"},{"key":"e_1_3_3_6_1","unstructured":"United States National Cancer Institute. Prostate Cancer Screening http:\/\/www.cancer.gov\/cancertopics\/pdq\/screening\/prostate\/HealthProfessional"},{"key":"e_1_3_3_7_1","unstructured":"American Association of Family Physicians. Prostate Cancer http:\/\/www.aafp.org\/online\/en\/home\/clinical\/exam\/prostatecancer.html"},{"key":"e_1_3_3_8_1","unstructured":"American College of Preventative Medicine. Screening For Prostate Cancer in American Men http:\/\/www.acpm.org\/prostate.htm"},{"key":"e_1_3_3_9_1","unstructured":"UK National Health Service. Information for PSA test for prostate cancer http:\/\/www.cancerscreening.nhs.uk\/prostate\/informationpack.html"},{"key":"e_1_3_3_10_1","unstructured":"Klein E. Active Surveillance Underutilized in Prostate Cancer. Medscape Medical News 2 March (2007) www.medscape.com\/viewarticle\/553065 (Accessed 20March2007)"},{"key":"e_1_3_3_11_1","unstructured":"American Cancer Society. Lifetime risk of developing or dying from cancer http:\/\/www.cancer.org\/Cancer\/CancerBasics\/lifetime-probability-of-developing-or-dying-from-cancer"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm.11.53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T05:31:57Z","timestamp":1741498317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm.11.53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.2217\/bmm.11.53"],"URL":"https:\/\/doi.org\/10.2217\/bmm.11.53","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"value":"1752-0363","type":"print"},{"value":"1752-0371","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}